Mercado de Polymarket

Prediction market

Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.

Proximo
Probabilidad
32%
Liquidez
$1.56K
Mejor compra
1%
Mejor venta
99%
Spread
98%
Ultimo trade
32%

Outcomes

Resultados del mercado

Yes 32% Current quote
No 32% Current quote

Precio en vivo

Precio y liquidez

Compra, venta, punto medio, spread y profundidad actuales para este resultado.

Mejor compra
1%
Mejor venta
99%
Punto medio
50%
Spread
98%
Ultimo trade
32%
Profundidad
1078,87 / 478,35

Historial de precios

Esperando historial de precios

Historial no disponible

Compras

PrecioTamano
1%115
18%300
26%134.61
28%49
30%89.81
31%89.81
32%30
54%18.64

Ventas

PrecioTamano
99%115
98%55,27
97%13,06
95%27
94%27
93%54
92%30
72%47,28

Trades

Trades recientes

Latest visible trades for this market.

  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 68% 16.66 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 30% 5.66 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 71% 4.86 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 37% 30 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 62% 6.45 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 59% 25.42 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 33.1% 140 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 57% 7 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 57% 54 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 44% 8 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 40% 30 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 36.2% 151 shares